Search
Q C Technologies Ord Shs
QCLSAdd to Watchlist
4.540USD
-0.590-11.50%
Market hours （ET）Quotes delayed by 15 min
34.91MMarket Cap
LossP/E TTM
More Details of Company
Q C Technologies Ord Shs Info
Ticker Symbol- -
Company name- -
IPO date- -
CEO- -
Number of employees- -
Security type- -
Fiscal year-end- -
Address- -
City- -
Stock exchange- -
Country- -
Postal code- -
Phone- -
Website- -
Ticker Symbol- -
IPO date- -
CEO- -
Company Executives of Q C Technologies Ord Shs
Name
Name/Position
Position
Shareholding
Change
Mr. Stephen Friscia
Mr. Stephen Friscia
Independent Director
Independent Director
27.16K
+84.09%
Dr. Mitchell Glass, M.D.
Dr. Mitchell Glass, M.D.
Chief Medical Officer, Director
Chief Medical Officer, Director
13.58K
+84.09%
Mr. Christopher C. Schreiber
Mr. Christopher C. Schreiber
Director
Director
30.00
+3.33%
Mr. Bill Joe White
Mr. Bill Joe White
Independent Director
Independent Director
--
--
Mr. Joshua N. (Josh) Silverman
Mr. Joshua N. (Josh) Silverman
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Mr. Ian Rhodes
Mr. Ian Rhodes
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--
Mr. Robert Schatz
Mr. Robert Schatz
Investor Relations
Investor Relations
--
--
Mr. Bruce Bernstein
Mr. Bruce Bernstein
Director
Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Stephen Friscia
Mr. Stephen Friscia
Independent Director
Independent Director
27.16K
+84.09%
Dr. Mitchell Glass, M.D.
Dr. Mitchell Glass, M.D.
Chief Medical Officer, Director
Chief Medical Officer, Director
13.58K
+84.09%
Mr. Christopher C. Schreiber
Mr. Christopher C. Schreiber
Director
Director
30.00
+3.33%
Mr. Bill Joe White
Mr. Bill Joe White
Independent Director
Independent Director
--
--
Mr. Joshua N. (Josh) Silverman
Mr. Joshua N. (Josh) Silverman
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Mr. Ian Rhodes
Mr. Ian Rhodes
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--
Revenue Breakdown
Currency: USDUpdated: Tue, Dec 9
Currency: USDUpdated: Tue, Dec 9
FY2019
By BusinessUSD
Name
Revenue
Proportion
Particle ImmunoFiltration Assay (“PIFA”)
1.33M
84.19%
MicroParticle Catalyzed Biosensor (“MPC”)
126.15K
8.00%
Rapid Enzymatic Assay (“REA”)
85.00K
5.39%
Other
38.13K
2.42%
By RegionUSD
Name
Revenue
Proportion
United States
1.56M
98.89%
Rest of the World
17.50K
1.11%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Particle ImmunoFiltration Assay (“PIFA”)
1.33M
84.19%
MicroParticle Catalyzed Biosensor (“MPC”)
126.15K
8.00%
Rapid Enzymatic Assay (“REA”)
85.00K
5.39%
Other
38.13K
2.42%
Shareholding Stats
Updated: Wed, May 13
Updated: Wed, May 13
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Private Advisor Group LLC
4.25%
Silverman (Joshua)
3.45%
Voss (Chelsea Sierra)
3.05%
Quinn Opportunity Partners LLC
2.69%
Jane Street Capital, L.L.C.
1.61%
Other
84.95%
Shareholders
Shareholders
Proportion
Private Advisor Group LLC
4.25%
Silverman (Joshua)
3.45%
Voss (Chelsea Sierra)
3.05%
Quinn Opportunity Partners LLC
2.69%
Jane Street Capital, L.L.C.
1.61%
Other
84.95%
Shareholder Types
Shareholders
Proportion
Individual Investor
7.85%
Hedge Fund
2.84%
Investment Advisor
1.67%
Research Firm
0.98%
Investment Advisor/Hedge Fund
0.62%
Other
86.05%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q4
33
22.85K
0.28%
--
2026Q1
53
532.59K
6.78%
+139.51K
2025Q4
69
101.39K
2.43%
+63.14K
2025Q3
77
16.99K
0.47%
+2.10K
2025Q2
83
5.39K
3.87%
-6.21K
2025Q1
79
4.88K
13.08%
-5.98K
2024Q4
85
4.17K
15.30%
-5.82K
2024Q3
86
442.00
1.99%
-9.58K
2024Q2
84
9.45K
43.70%
+7.33K
2024Q1
87
9.25K
42.96%
+6.52K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Private Advisor Group LLC
333.83K
8.01%
+333.83K
--
Dec 31, 2025
Silverman (Joshua)
108.67K
2.61%
+91.36K
+527.55%
Nov 14, 2025
Voss (Chelsea Sierra)
239.90K
5.76%
+239.90K
--
Jan 16, 2026
Quinn Opportunity Partners LLC
211.39K
5.07%
+211.39K
--
Dec 31, 2025
Jane Street Capital, L.L.C.
40.49K
0.97%
+40.49K
--
Dec 31, 2025
UBS Financial Services, Inc.
17.43K
0.42%
+12.29K
+239.27%
Dec 31, 2025
Virtu Americas LLC
35.38K
0.85%
+35.38K
--
Dec 31, 2025
Geode Capital Management, L.L.C.
29.25K
0.7%
+29.25K
--
Dec 31, 2025
White (Billy Joe)
27.18K
0.65%
+22.84K
+525.52%
Nov 14, 2025
View more
Related ETFs
Updated: Tue, Dec 9
Updated: Tue, Dec 9
Name
Proportion
Cambria Cannabis ETF
0%
Dimensional US Core Equity 1 ETF
0%
iShares Micro-Cap ETF
0%
Cambria Cannabis ETF
Proportion0%
Dimensional US Core Equity 1 ETF
Proportion0%
iShares Micro-Cap ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Splits
Date
Ex-dividend Date
Type
Ratio
Aug 28, 2025
Merger
100→1
Feb 13, 2024
Merger
30→1
Date
Ex-dividend Date
Type
Ratio
Aug 28, 2025
Merger
100→1
Feb 13, 2024
Merger
30→1
